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Abstract
Background: Formulation of DNA/cationic lipid complexes (lipoplexes) designed for nucleic acid delivery mostly results in
positively charged particles which are thought to enter cells by endocytosis. We recently developed a lipoplex formulation
called Neutraplex that allows preparation of both cationic and anionic stable complexes with similar lipid content and
ultrastructure.
Methodology/Principal Findings: To assess whether the global net charge could influence cell uptake and activity of the
transported oligonucleotides (ON), we prepared lipoplexes with positive and negative charges and compared: (i) their
physicochemical properties by zeta potential analysis and dynamic light scattering, (ii) their cell uptake by fluorescence
microscopy and flow cytometry, and (iii) the biological activity of the transported ON using a splicing correction assay. We
show that positively or negatively charged lipoplexes enter cells cells using both temperature-dependent and -independent
uptake mechanisms. Specifically, positively charged lipoplexes predominantly use a temperature-dependent transport
when cells are incubated OptiMEM medium. Anionic lipoplexes favour an energy-independent transport and show higher
ON activity than cationic lipoplexes in presence of serum. However, lipoplexes with high positive global net charge and
OptiMEM medium give the highest uptake and ON activity levels.
Conclusions: These findings suggest that, in addition to endocytosis, lipoplexes may enter cell via a temperature-
independent mechanism, which could be mediated by lipid mixing. Such characteristics might arise from the specific
lipoplex ultrastructure and should be taken into consideration when developing lipoplexes designed for in vivo or ex vivo
nucleic acid transfer.
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Introduction
Non-viral DNA delivery systems have been developed to
facilitate gene entry into mammalian cells. Among the poly-
charged vectors currently used, DNA/cationic lipid complexes
(lipoplexes) [1] seem promising candidates since they deliver
nucleic acids efficiently both in vitro and in vivo [1,2,3,4]. Indeed,
various systems are now commercially available for lipoplex-
mediated transfection (lipofection) of cultured cells and 7.1% of
the current gene therapy clinical trials concern the evaluation of
lipoplex formulations to deliver genes, active molecules or drugs
(www.wiley.co.uk/genetherapy/clinical/). However, despite the
great success for in vitro transfection, cationic lipoplexes often
exhibit significant drawbacks when used for in vivo delivery.
Indeed, plasma proteins with anionic charges may non-specifically
bind to positively-charged lipoplexes and rapidly remove them
from the circulation via the reticulo-endothelial system [3]. Plasma
proteins might also greatly alter lipoplex structure leading to
aggregation and enhanced clearance or deterioration by serum
nucleases. Opsonization and activation of the complement system
[5] by lipoplexes are additional physiological phenomena that can
participate in lowering the efficacy of intravenously (i.v.)
administered cationic lipoplexes. Moreover, pharmacokinetic
analysis of lipid-based delivery systems has revealed that, in the
case of systemic administration, ‘‘first-pass’’ organs and those with
a high degree of vascularization and blood flow (heart, lung, liver,
spleen) exhibit significantly higher expression of the transfected
molecule [2,3,6,7] that is, consequently, cleared from the system
very rapidly.
To overcome these drawbacks, great effort has been put into
the formulation of stable cationic lipoplexes that can be
successfully used in vivo [8]. We previously showed that lipoplexes
with low net charge ratio exhibit higher gene or ON transfer
following i.v. injection in almost all organs tested [2,9].
Therefore, we designed a second generation vector system called
Neutraplex (Nx) that allows the generation of negatively charged
and stable lipoplexes [3,10] thanks to the insertion of cardiolipin
(CL) in the lipid composition. CL is a negatively charged
phospholipid with specific chemical and biological properties that
allow, first, the association (usually unstable) of lipids of opposite
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generate positively or negatively charged stable lipoplexes by only
varying the DNA/lipid ratio [11]. Pharmacokinetic and bio-
availability studies following the i.v. administration of an ON
delivered either in free form, or using a cationic or a negatively
charged Nx system in baboons [3] showed that Nx allowed to
obtain high transfection efficiency with good distribution and
slower clearance than classical cationic lipoplexes and without
toxicity [3].
Another way to improve efficiency of ON transfection and
activity would be to create molecules which can more easily enter
the cells. However, despite several studies to investigate the
mechanisms of uptake and intracellular trafficking of non-viral
vectors to improve delivery, the current understanding of these
processes is still limited. Endocytosis is generally considered to be
the main entering pathway for lipoplexes [12–15]. Eukaryotic cells
use several endocytic pathways to internalize a variety of
substances and to accomplish different tasks: the clathrin-
dependent pathway [16], phagocytosis [17], macropinocytosis
[18] and the caveolin-dependent pathway [19]. Phagocytosis is
restricted to specialized cells including macrophages, monocytes
and neutrophiles [20]. Macropinocytosis is mainly used to
internalize polyplexes, and less commonly for lipoplexes [21].
The type of endocytosis also depends upon the particle size [22].
In receptor-mediated endocytosis, small particles (,250 nm) are
mainly internalized through the clathrin-mediated pathway, a non
specific mechanism. This pathway is initiated by the formation of
clathrin-coated pits that leads to the development of early and late
endosomes, which ultimately fuse with lysosomes [23]. Larger
particles ($500 nm) generally enter the cells through caveolae
[22,23]. Although endocytosis has been proposed as the main
pathway for lipoplex entry, a fusion mechanism has been also
proposed in a few studies [24,25]. An exchange mechanism could
thus take place between lipoplexes and plasma membranes that
would lead to destabilization of the lipoplex structure, DNA
disassembling from the complex with delivery directly into the cell
cytoplasm [1,26].
Here we wanted to understand to which extent the surface
charge of the lipoplexes influences the choice of cell internalization
pathway. To this aim, we used the Neutraplex delivery system to
prepare particles with the same lipid composition and structure
but that are either positively or negatively charged. In this way we
could directly compare their efficacy in delivering an ON into
HeLa cells by analysing their uptake pathway, intracellular
distribution and biological activity.
Materials and Methods
Cell line
HeLa cells stably transfected with the pLuc/705 plasmid
(HeLa pLuc/705), in which the coding region of luciferase is
interrupted by the mutated b-globin intron [28], were grown at
37uC, 5% CO2 in minimal essential DMEM medium (Gibco,
Invitrogen SARL, Cergy Pontoise, France) supplemented with
10% foetal bovine serum (FCS), 1% Na pyruvate, non essential
amino acids and a mix of penicillin, streptomycin and neomycin
(1006, Gibco). Cells were checked every 3 weeks for the
absence of mycoplasma contamination by using the PCR
enzyme immunoassay mycoplasma detection kit (Roche Diag-
nostics).
Antisense oligonucleotides
The 18-mer phosphodiester 2’O-methyl-oligoribonucleotides
were purchased from Eurogentec SA (Seraing, Belgium). ON705
(CCU CUU ACC UCA GUU ACA) is the antisense (AS)
sequence, targeted to an aberrant splice site that is created by a T
to G mutation at nucleotide 705 of intron 2 of the b-globin in b-
thalassemic patients [28]. ONSC (ACU ACC CGA UAU CUC
CUC) is the scrambled (SC) version of ON705. For fluorescence
microscopy and flow cytometry, 59-FITC- or 59-Alexa546-labelled
ON were used.
Lipoplex formulations
The liposomes used for lipoplex (DLS and Nx) preparations
consisted of small unilamellar vesicles (SUV) that can complex to
negatively-charged ON. Neutraplex SUV were prepared by
mixing 1 mg DOGS, 1 mg DOPE or FITC-labelled DOPE
(Sigma-Aldrich Chimie SARL, St Quentin Fallavier, France) and
0.5 mg cardiolipin (CL, Sigma) in 50 ml ethanol and subsequently
by adding excess pure water (6.25 mg lipid/mL, final) [3,10].
Lipoplexes were obtained by mixing the SUV suspension with
ON, at several lipid/ON weight ratios. Cationic (Nx+) and anionic
(Nx2) lipoplexes were prepared, depending on the ON load
charge in the formulation. Nx+20 or Nx240 preparations
corresponded to 20 or 40 mg ON with 156 mg total lipids,
respectively. Typically, one Nx+20 preparation contained 128 mg
ON/mg total lipids. DLS (Delivery Liposomal System) lipoplexes
were prepared with DOGS and DOPE only, as previously
described [29–31]. DLS/ON had a 10 mg ON to 185 mg total
lipids ratio. DLS/ON preparation contained 54 mg ON/mg total
lipids. Lipoplexes were stored at 4uC and used within 3 months
from preparation.
Particle size distribution and zeta potential analysis
Particle size and zeta potential were measured using a Malvern
Zetasizer Nano ZS apparatus (Malvern Instruments, Orsay,
France). All samples were kept at room temperature for 15 min
prior to measurement and were analyzed undiluted. Sample
analysis were carried out in automatic mode with the following
parameters: scattering angle, 173u; temperature, 25uC; medium
viscosity, 0.887 cP. Average diameters were evaluated as a Z-
average using a monomodal method (NNLS cumulant analysis).
Particle size data are expressed as hydrodynamic diameter vs.
intensity. Coefficient of variation of our mean particle measure-
ment under the experimental conditions is 15%. Zeta potential
measurements were carried out using the M3-PALS technology.
Width at half peak height is indicative of the homogeneity of size
and charge distribution.
Transfections and reporter gene assays
3.5610
5 HeLa pLuc/705 cells/well were seeded in 6-well dishes
with 10% FCS-containing medium. After overnight culture (16–
20 h), cells were rinsed twice with PBS and the medium was
replaced with the OptiMEM medium or the DMEM medium
containing decomplemented FCS (Invitrogen). OptiMEM (Invi-
trogen) is a supplemented synthetic medium. Lipoplexes were then
added to the cells and luciferase activity was monitored 24 h later.
Cells were rinsed twice with PBS and 300 ml Reporter Lysis Buffer
(Promega France, Charbonnieres) was added. Protein concentra-
tion in the extracts was measured with the BCA
TM Protein Assay
Kit (Pierce, Perbio Science France, Brebieres) at 560 nm. Firefly
luciferase activity was measured using a Luciferase Assay Kit
(Promega) and was quantified in the supernatant with a Berthold
Centro LB 960 luminometer (Berthold France SA, Thoiry).
Luciferase activity in cultured cells was expressed as relative light
units (RLU) per mg of protein. Each data point was averaged over
three replicates.
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After carrying out the luciferase and BCA
TM Protein assays, cell
lysate leftovers (about 270 ml) were transferred into 2 mL
microfuge tubes and total RNA was extracted with 1 mL TRI
Reagent (Sigma), according to the manufacturer’s instructions.
Specifically, 0.3 mL of chloroform was used for extraction and the
amount of isopropanol for RNA precipitation was increased to
give a 1:1 mixture with the aqueous phase. RNA was quantified by
RT-PCR amplification (MJ Research PTC200 Peltier Thermal
cycler) with 59 TTG ATA TGT GGA TTT CGA GTC GTC 39
(forward primer) and 59 TGT CAA TCA GAG TGC TTT TGG
CG 39 (reverse primer) and the SuperScript One-Step RT-PCR
System with Platinum Taq (Invitrogen). Products were run on a
2% agarose gels, scanned and analyzed using the Gene Tools
Analysis Software (SynGene, Cambridge, UK).
Flow cytometry
5610
5 HeLa pLuc/705 cells/well were plated in 6-well dishes.
After overnight culture, cells were incubated with lipoplexes
containing 59-FITC-labelled ON705 in OptiMEM or in DMEM
with decomplemented serum at 37uCo r4 uC (by keeping cells on
ice) for evaluating the contribution of the temperature-dependent
or -independent uptake (TDU or TIU, respectively). After 1, 3 or
6 h incubation, cells were rinsed twice with cold PBS, centrifuged
at 4uC, resuspended in 300 ml cold PBS, in polystyrene tubes, and
kept on ice until analysis. Cells to be transfected at 4uC were pre-
incubated at this temperature for one hour. To strip-off lipoplexes
bound at the cell surface, cells were treated with 1 mL glycine
(0.2 M, pH=2.8) for 30 min at 4uC and rinsed in ice cold PBS
before FACS analysis [26,27]. We determined the fluorescence
intensity values corresponding to: FA, the fluorescence intensity of
cells incubated at 37uC; FB, the fluorescence intensity of cells
incubated at 4uC; FC, the fluorescence intensity of glycine- treated
cells. We calculated:
N cell surface bound ON=FA-FC,
N TIU=FB-cell surface bound ON,
N TDU=FA-TIU-cell surface bound ON.
Flow cytometry was performed with a FACS Canto (BD
Biosciences France, Le Pont De Claix, France). Fluorescence
intensity of 10,000 events was recorded at 520 nm after excitation
at 488 nm. Results were analyzed with the WinMDI Software.
Each experiment was performed in duplicate and each data point
was averaged over two replicates.
Live cell observation by fluorescence microscopy
5610
5 HeLa pLuc/705 cells/well were plated in 35 mm dishes.
Following overnight culture, cells were treated with lipoplexes with
59-FITC-labelled-DOPE (Sigma) or 59-Alexa546-labelled ON705
(Eurogentec), in 10% FCS-containing medium. Living cells were
directly observed in the dish with 1 mL of 10% FCS-containing
medium, after 1 to 24 h of transfection. Fluorescence distribution
was analyzed on a Zeiss Axiovert 200 M fluorescence microscope
without fixation (Carl Zeiss, Oberkochen, Germany), with an663
objective. Images were first acquired with the AxioVision software
and, after exportation, they were analyzed with Adobe Photoshop
and ImageJ.
Cytotoxicity assay
Cell viability and cytotoxicity studies were performed by plating
pLuc/705 HeLa cells in 96-well plates at 3610
4 cells/well. Cells
were incubated with lipoplexes containing different ON concen-
trations for 24 h in OptiMEM or in DMEM with decomplemen-
ted serum. The proportion of live cells was determined using the
tetrazolium-based colorimetric cell proliferation assay (MTS,
Promega) by reading the absorbance at 560 nm. Data are
expressed as the percentage of cytotoxicity (relative to untreated
cells).
Statistical analysis
Data were expressed as mean6standard deviation. Statistical
analyses were performed using Student’s t test for comparison of
means. A probability of less than 0.05 was considered to be
statistically significant.
Results
Physico-chemical properties and cytotoxicity of
lipoplexes with different charges
To assess whether the surface charge of lipoplexes could
influence the choice of cell internalization pathway we used two
different formulations of liposomes to prepare lipoplexes: DLS that
allows to obtain cationic lipoplexes with a low net charge ratio and
Nx to prepare positively or negatively charged lipoplexes. First, we
compared the physico-chemical properties of the different
liposomes and lipoplexes by measuring the particle size range by
Dynamic Light Scattering and the surface charge by zeta potential
(Table 1). Homogeneous lipid particles were obtained with both
formulations (Data S1). No particles larger than 600 nm were
detected in any formulation. The global net charge ratios of
positive charges in DOGS to negative charges in cardiolipin (CL)
and ON were calculated. Global net charge ratios of 1.8 for
Nx+20 and 1.0 for Nx240 were obtained, suggesting that Nx240
is the lipoplex preparation closest to neutrality. In comparison, we
obtained a ratio of 7.3 with the DLS formulation. ON are fully
protected in DLS or Nx lipoplexes when incubated for 4 hours in
serum with medium as assayed by electrophoresis (PAGE) (data
not shown). PAGE and cryo-electron microscopy analysis revealed
that no excess material was detected in Nx lipoplexes containing
10 to 40 mg ON. As formation of complexes with 25–30 mgO N
lead to global net charge neutralization and particles aggregation,
we decided to use Nx+20 and Nx240, as the positively and
negatively charged NxON.
We then tested the cytotoxicity of our preparations by
incubating HeLa pLuc/705 cells with DLS, Nx+ and Nx2
lipoplexes containing different concentrations of ON705 in the
Table 1. Physico-chemical characterization of the liposomes
and lipoplexes used in this study.
TYPE OF FORMULATION ON SIZE, nm
f POTENTIAL
(mV)
mean (width)
LIPOSOMES DLS 137 (149) N.D.
Nx 170 (22) N.D.
LIPOPLEX DLS/ON 2’O-Me 179 (25) +44
Nx+20/ON 2’O-Me 278 (245) +22
Nx240/ON 2’O-Me 203 (200) 237
Particles mean diameter was measured by dynamic light scattering and surface
charge by zeta potential. Particle size data are expressed as hydrodynamic
diameter vs. intensity. Width, half peak height. Nx+, cationic Nx lipoplexes. Nx2,
anionic Nx lipoplexes. Nx20 or 40, 20 or 40 mg ON mixed with 156 mg total
lipids, respectively. N.D., not determined.
doi:10.1371/journal.pone.0006058.t001
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tetrazolium-based colorimetric assay. Cells grown in OptiMEM
showed cytotoxicity starting from ON705 concentrations of
100 nM with DLS (Fig. 1B), of 500 nM with Nx2 (Fig. 1A),
and 1 mM with Nx+ (Fig. 1C) lipoplexes. No significant
cytotoxicity was observed in cells grown in DMEM with the three
formulations. Moreover, no decrease in protein concentration
compared to untreated cells under these conditions was observed.
As routinely observed when using DLS or Nx, higher cell growth
was detected when using Lx low concentration explaining the
‘‘negative’’ cytotoxicity experimentally calculated when compared
with non treated control cells (Fig. 1).
As a consequence, the concentrations of ON705 used for our
study (i.e., lower than 250 nM) did not cause detectable
cytotoxicity which could bias the interpretation of the results
especially when assessing the uptake mechanism.
Nx system internalizes ON
When using cationic lipoplexes, ON first concentrates in
endocytotic vesicles, corresponding to a punctuate staining in the
cytoplasm, and then, when they are free in cytoplasm, quickly
accumulate in nuclei [29–31] and especially in nucleoli [31,32].
After 6 h incubation, red fluorescence due to Alexa546-labelled
ON705, delivered either with Nx+20 (A) or with Nx2 40 (B), was
visible both in cytoplasm and in nuclei (arrows). Thus, the Nx
system appears to promote ON internalization in HeLa cells as
efficiently as more classical lipoplex formulations.
Internalization mechanisms
We then assessed the contribution of the different internaliza-
tion pathways when lipoplexes with different electrical global net
charges were used. Endocytosis, which is considered the main
route used by lipoplexes, transports inert particles of mean
Figure 1. Cytotoxicity of increasing concentrations of ON705 delivered with Nx240 (A), DLS (B), or with Nx+20 (C). HeLa pLuc/705 cells
were incubated with the different formulations in serum-containing medium (white bars) or in optiMEM (black bars) for 24 h. ON concentrations
complexed with the liposomes are indicated. The level of cytotoxicity was determined with the tetrazolium-based colorimetric cell proliferation assay
and expressed as percent of the cytotoxicity level in treated cells in comparison to non-treated cells. Cells incubated with 1% X-100 Triton are used as
positive control. Error bars show standard deviation (n=3).
doi:10.1371/journal.pone.0006058.g001
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cell uptake are performed by using conventional and specific
markers of the late and medium endocytosis, however their
respective contribution is not the purpose of our study. In addition,
although endocytotic inhibitors such as chloroquine, NaN3, filipin
or chlorpromazine are very helpful for studying drug intracellular
release or elucidating a specific endocytosis route as we did in our
laboratory for cell penetrating peptides [33], we decided to focus
on plasma membrane penetration. Transport through plasma
membrane mediated by lipid membrane fusion can not be
specifically detected by specific inhibitors, such, for instance,
fusion inhibitors like nigericin. Indeed, this ionophore highlights
fusion events that only involve transmembrane pH gradients
specific for instance of endocytic vesicles. For this reason, we
focused our analysis on the thermo-dependence of the uptake
mechanisms as endocytosis is an energy-dependent and temper-
ature-dependent process and thus does not take place at 4uC. In
order to assess the importance of endocytosis in the internalization
of DLS, Nx+ and Nx2 lipoplexes, we compared 59-FITC-ON705
intracellular uptake at 1, 3 and 6 hours after transfection of cells
kept at either 37uCo r4 uC (Fig. 2), since inter-membrane lipid
mixing is known to occur also at very low temperature
[13,15,34,35]. Moreover, in order to differentiate between non
specific cell membrane binding and lipid fusion within the cell
membrane, we incubated Nx-transfected HeLa pLuc/705 cells
with glycine buffer (0.2 M, pH 2.8) to strip off the surface-bound
ON prior to flow cytometry measurements [27,32]. This treatment
did not cause any cytotoxic effect in regards to microscopical
examination, cell growth and splice correction efficacy within the
time lapse between treatment and FACS analysis (data not shown).
The efficacy of this treatment is demonstrated, for instance, by the
observation that incubation with glycine of cells transfected with
Nx+/ON705 for 1 h led to about 70% decrease in total ON-
associated fluorescence (Fig. 3B and C). In addition, when cells
were incubated with Nx-ON in OptiMEM culture medium for
1 h, subsequent glycine treatment did not decrease fluorescence
intensity (Fig. 3D) demonstrating that glycine treatment did not
interfere with the measurement of intracellular 59-FITC-ON705.
When Nx+ was used to deliver 59-FITC-ON705 in cells grown in
OptiMEM (Figure 4B), temperature-dependent uptake (TDU)
appeared to increase with time (from 8% after 1 h to 65% after
6 h of incubation, respectively) while surface-bound fluorescence
decreased (from 71% to 7%). Temperature-independent uptake
(TIU) fluctuated between 20 and 30% during the entire period of
incubation. Conversely, in the presence of DMEM and serum, no
or very little variation in the respective contribution of TDU, TIU
and cell surface-bound was observed (from 25% to 31% for TDU,
from 25% to 42% for TIU and from 22% to 41% for aspecific
binding).
When Nx2 was used to deliver 59-FITC-ON705 in cells grown
in OptiMEM (Figure 4B), no or vey little membrane-bound 59-
FITC-ON705 was detected, while TIU appeared to be the
preferred uptake mechanism (from 55% after 1 h to 67% after
6 h of incubation). In the presence of DMEM and serum,
however, 59-FITC-ON705 showed mainly a TDU at the beginning
(62% at 1 h) which then slowly decreased to 23% after 6 h of
incubation, while TIU represent about 50% of the uptake at the
same time point. Finally, overall cell uptake was higher with Nx+
than Nx2 lipoplexes (4 and 2 -fold higher in optiMEM and
DMEM, respectively). In conclusion, cationic lipoplexes exhibit
the highest uptake level and favour TDU when cells are incubated
in OptiMEM. TIU appears predominant when cells are treated in
serum-containing medium. TIU and TDU are similarly used by
anionic lipoplexes independently from the chosen incubation
medium.
We then followed by live microscopy the fate of Alexa546-
labelled ON705 and of one of the lipids (FITC-labelled DOPE) of
the Nx formulation under different experimental conditions.
Figure 5 shows HeLa pLuc/705 cells grown in OptiMEM and
incubated with Nx240 and 250 nM of Alexa546-labelled ON705 at
4uC for 1 hr, i.e., experimental conditions that favour TIU (see
Fig. 4). FITC-labelled DOPE (Figure 5C and Data S1, green) was
both diffused in the cytoplasm and localized along the plasma
membrane, suggesting fusion and displacement of the lipid within
the membrane. Alexa546-labelled ON705 (Figure 5B, in red) was
concentrated in endosomes and weakly distributed in the
cytoplasm, probably due to low local concentration at this early
time point. Partial nuclear localisation was observed after 6 hr of
incubation but not after 1 hr of incubation (Figure 2).
Splicing assay
In order to compare lipoplex efficacy in cell uptake and in
delivering biologically active ON, we used a splicing correction
Figure 2. Epifluorescence images of unfixed HeLa pLuc/705
cells incubated with 200 nM Alexa546-labelled ON705 delivered
with Nx+20 (A) or Nx240 (B). Nuclei were stained with Hoechst
(blue fluorescence) for 5 min. Living cells were directly observed under
red and blue epifluorescence in PBS supplemented with 5% FCS,
following 6 h incubation at 37uC. Intracellular ON appears in red and
intranuclear ON in pink (arrows), whereas nuclei without ON are blue.
doi:10.1371/journal.pone.0006058.g002
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pLuc/705 cells incubated with Nx+20 (A, B, C) or Nx240 (D) lipoplexes are shown. Cells were incubated with 100 nM of 59-FITC-labelled ON705
delivered with Nx+20 or Nx240 lipoplexes. After 1 h incubation in optiMEM, at 4 or 37uC, Cells were rinsed with PBS and treated, or not, with glycine.
ON binding to cell membrane was calculated by subtracting the fluorescence intensity of glycine-treated cells from that of non-treated cells.
Estimation of TIU was determined as the fluorescence intensity of cells incubated at 4uC and treated with glycine buffer. Estimation of TDU was
calculated by subtracting the sum of the fluorescence intensities corresponding to TIU and cell surface bound ON from the fluorescence intensity of
cells incubated at 37uC. NT, non-treated cells. Two samples were used for each condition.
doi:10.1371/journal.pone.0006058.g003
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100 nM ON705 in DLS or in Nx+20 and Nx240 in DMEM and
serum (Figure 6A) or OptiMEM alone (Figure 6B). When
considering only the Nx formulation, Nx+20 appeared to be the
most efficient formulation (Fig. 6). Splicing correction activity of
Nx+20-ON705 was about twice than that of Nx240-ON705.I n
dose curves experiments, incubation of cells in serum-containing
medium with Nx+20 and Nx240 led to a statistically significant
difference in terms of luciferase activity compared to control
(ODSC) at 100 nM (p,0.001) and 10 nM (p,0.01) (data not
shown). ON705 delivered with DLS presented a 5–10 times lower
activity in medium with serum (22,000 RLU/mg Prot., data not
shown), but, as shown in Fig. 6, the DLS system was 8-fold more
efficient than Nx+20 in the absence of serum.
Discussion
In this work we show that: (i) it is possible to obtain homogenous
and stable negatively or positively charged lipoplexes able to
transfect cells, (ii) lipoplexes enter cells by either a temperature–
dependent (TDU) or -independent mechanism (TIU), (iii)
transfected ON activity depends on the type of lipoplexes used
and the presence/absence of serum in the cell culture medium.
The study of the influence of particle charge of lipoplexes on
cellular uptake or biological activity was made possible by the
Figure 4. Estimation of the percentage (%) of temperature-dependent (TDU), independent uptake (TIU) and cell surface bound 59-
FITC-labelled ON705 delivered with DLS, Nx+20 or Nx240 lipoplexes in HeLa pLuc/705 cells. Following 3 h (A) or 1, 3 and 6 h (B)
incubation in serum-containing culture medium (DMEM) or OptiMEM, at 4 or 37uC, cells were rinsed with PBS and treated, or not, with glycine. Then,
cells were subjected to flow cytometric analysis. Evaluation of ON fixation onto cells was calculated by subtracting the fluorescence intensity of
glycine-treated cells from that of untreated cells. Evaluation of TIU was calculated by subtracting the fluorescence intensity corresponding to cell
surface bound ON from the fluorescence intensity of untreated cells incubated at 4uC. Evaluation of TDU was calculated by subtracting fluorescence
intensity corresponding to the sum of the cell surface bound ON and TIU fluorescence intensities from the fluorescence intensity of cells incubated at
37uC. Two samples were used for each condition.
doi:10.1371/journal.pone.0006058.g004
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either positive or negative charges and the same lipids (vector)
composition [3,10]. Lipoplexes formation is based on the
Manning-Oosawa counter ion reaction that leads to compaction
of nucleic acids (NA)/lipid complex which, under specific
preparation processes, generate small and stable particles. To
ensure complete DNA or ON counter ion condensation, excess of
positive charges is usually needed to obtain stable complexes for
most previously described lipoplex preparation, but for the
Neutraplex system.
Data on the cytotoxicity of the different lipoplexes used in this
study confirm that cationic lipoplexes are more toxic than the
anionic ones. This effect is more pronounced when cells are
incubated in OptiMEM than in serum-containing medium,
highlighting the affinity of cationic lipoplexes for the cell surface
and the fact that their binding with anionic serum proteins seems
to strongly inhibit their cell uptake. Therefore, the strategy of using
cationic lipoplexes to take advantage of interactions with the
negative charges at the cell surface, such as in endothelial cells,
appears restricted. In addition, the non-specific binding of
positively charged particles to blood proteins greatly and rapidly
neutralizes the net positive surface charge. Previous work has
demonstrated the successful use of neutral or negatively charged
liposomes to transfer the encapsulated plasmid DNA following
systemic injection in rodents [35,36]. These examples show that
high plasmid DNA compaction and cationicity are not absolute
requirements for successful gene transfer.
Formation of anionic Nx was made possible by the insertion of
cardiolipin (CL) in the lipid composition. CL is a negatively
charged phospholipid with particular chemical and biological
properties that allow, first, the association (usually unstable) of
lipids of opposite charge and, second, the elaboration of a versatile
formulation generating positively or negatively charged, stable
lipoplexes by only varying NA/lipid ratio [11]. Such Nx
supramolecular assemblies are of spherical shape and exhibit a
specific liquid crystal ultrastructure in which DNA is circumfer-
entially packaged in a lipid bilayer [10]. CL does not specifically
leads to this specific ultrastructure, as it was observed for DLS/
Figure 5. Epifluorescence images of unfixed HeLa pLuc/705 cells incubated with 250 nM Alexa546-labelled ON705 (red fluorescence)
delivered with the Nx240 system containing FITC-labelled lipids (green fluorescence). Living cells were directly observed in PBS
supplemented with 5% FCS, after 1 h incubation at 37uC. (A), (B), (C) and (D) are images of the same field of observation. Images of cells were taken
under visible light (A), red (B) or green (C) epifluorescence, and the three (A–C) images were then merged (D). Images are focused on cell membrane
to observe lipid distribution consecutive to lipid exchange at the plasma cell membrane (white arrows).
doi:10.1371/journal.pone.0006058.g005
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from lamellar to hexagonal phase [10,11,38]. CL is considered to
favour the hexagonal ultrastructure and to enhance lipid
membrane fusion. Indeed, we showed [38] that Nx/plasmid
DNA particles have a higher proportion of hexagonal structures
than DLS/plasmid DNA. The same Nx formulation with high
molecular weight DNA (T4 phage DNA) led to mostly hexagonal
structures as determined by cryo-electron microscopy and Small
Angle X-rays diffraction [10,38]. The emerging viewpoint is that
structural changes of lipoplexes upon interaction with anionic
cellular lipids may regulate lipofection efficiency [39].
Our work clearly demonstrates that TDU was the major uptake
mechanism for cationic particles, especially for DLS and Nx+ in
OptiMEM (62 and 66%, respectively for 3 and 6 h) like in
previous studies [12–15]. However, TIU represented up to 62%
for Nx2 in serum-containing medium.
The high positive global net charge of DLS lipoplexes compared
to Nx+20 (7.3 versus 2.0) might account for the higher contribution
of TDU compared to TIU (2-fold compared to 0.6-fold) (Fig. 6A
and B). This might be as well observed with commercially
available cationic lipid systems or other systems with high global
net charge ratio such as Lipofectamine (Invitrogene) (13.5). It has
to be noted that Lipofectamine performs very poorly in splicing
correction assay when used in serum-containing medium [29,30].
Our results show that anionic particles can easily enter the cell
despite the negatively charged proteoglycans located onto plasma
membrane, which have been described as mediators for the uptake
of cationic lipoplexes. Generally, increasing the negative charge in
lipoplexes led to a decrease in membrane binding and a gradual
decrease in TDU while increasing ON activity when serum is
present in transfection medium. Conversely, increasing the
positive charges led to an increase both of TDU and ON activity
in optiMEM transfection medium. Membrane binding of cationic
or anionic lipoplexes showed to increase with time in serum-
containing medium, whereas it appeared fast and saturable when
using OptiMEM.
These findings indicate that TIU might be, together with
endocytosis, a significant pathway by which lipoplexes penetrate
into the cell and release ON in the cytoplasm. We might
hypothesize that TIU happens partly through lipid exchange at
the cell membrane. Lipoplex fusion with inner membranes to
promote ON release from endocytic vesicles following endocytosis
was previously observed. Only few authors, reporting on highly
efficient multi-component lipoplexes, have previously hypothe-
sized that lipid mixing entropy may play a key role in the
mechanism of internalization [40]. Several lipids (DOTAP,
DOTMA, DOPE, CL) and polymers (PEG) that may facilitate
lipoplex fusion with the plasma membrane [1,3,41–43] or with the
endosome membrane [44] have been described. Nucleic acid
delivery is efficiently achieved by viruses which penetrate through
the plasma membrane by spontaneous merger of membranes
promoted by fusion protein catalysts. A clear understanding of the
thermodynamics and lipids rearrangements involved in this
process remains incomplete [45]. Insertion of a fusion protein
inside unilamellar liposomes was shown to promote lipid mixing
and membrane fusion facilitating intracellular penetration of
Figure 6. RT-PCR analysis of splice correction. HeLa pLuc/705 cells were incubated for 24 h in serum-containing-medium or OptiMEM, in the
absence (NT) or in the presence of 100 nM ON705 delivered with the Nx or the DLS system. Cell samples were then divided in two. One fraction was
lysed in lysis buffer and splicing correction was quantified by measuring luciferase activity as described in Material and Methods. The other cell
fraction was subjected to total RNA extraction and amplification by RT-PCR. PCR products from incorrectly (268 bp) and correctly (142 bp) spliced
samples were run on 2% agarose gels. Nx20 or 40, 20 or 40 mg ON mixed with 156 mg total lipids, respectively (surface charge, +22 and 237,
respectively). DLS/ON has a 10 mgO Nt o9 5mg total lipids ratio (surface charge, +44).
doi:10.1371/journal.pone.0006058.g006
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established that synthetic membrane vesicles could merge by
fusion of lipid membranes when using, in liposome composition,
lipids supporting formation of the hexagonal HII phase. Among
those are phosphatidylethanolamine and cardiolipin which are
constituents of the Nx lipoplexes. Large unilamellar vesicles
containing cardiolipin undergo membrane fusion and lamellar-to-
inverted hexagonal phase transition in presence of Ca
2+ [46]. Non-
leaky fusion of the vesicles over rapid collapse into HII structures
was observed at temperatures ranging between 0 and 50uC
[34,45]. Membrane fusion of a synthetic vesicle in live cells is
poorly described [41–43]. Biological membrane fusion is a
localized, fast (less than a millisecond) and a well controlled (non
leaky) process. It could be assumed that anionic lipids laterally
diffuse in the lipoplex membrane surface neutralizing the cationic
lipids in a flip-flop process and consequently release ON as
postulated by Zelphati and Szoka for the endosomal release [14].
HII phase have been observed by electron microscopy in both
prokaryotic and eukaryotic membranes but various aspects of
biomembranes heterogeneity during membrane fusion are not
fully elucidated. As a consequence, it is conceivable to hypothesize
that lipid exchange might occur at 4uC and might contribute to
the intracellular transport of ON at higher temperature. We
observed that high TIU is correlated with low levels of cell surface
bound ON, in particular when delivered with Nx2.W e
hypothesize that lipid fusion is a fast process or/and that cell
surface proteoglycans might maintain lipoplexes at the plasma
membrane holding back penetration. We suggest that TIU,
observed when using the Neutraplex lipoplexes, might be due to
lipid mixing and concomitant membrane fusion. Certainly, the use
of cardiolipin in presence of a cationic compound and the specific
highly ordered ultrastructure promoting lamellar to hexagonal
phase transition of Nx [10] could be important factors to facilitate
lipid mixing with plasma or endocytic vesicle membranes and
release of free ON in the cytoplasm. A fusion mechanism bypasses
the vesicular endocytic traffic avoiding lysosome hydrolytic
enzymes and, therefore, could lead to higher ON release. This
pathway could be more efficient compared to endocytosis in some
conditions. Cell lines develop high endocytic activity with
consecutive cell culture passages; therefore, the use of high
passage cells in combination with lipoplexes of high net global
charge ratio certainly led to the assumption that endocytosis is the
main uptake mechanism. It has to be noted that primary cells or
haematopoietic cells, such as peripheral blood mononuclear cells,
are difficult to transfect possibly due to their poor ability to elicit
endocytosis. We also observed that mesenchymal stem cells
promoted lipid exchange mechanism to take up lipoplexes (data
not shown). We believe that the possibility of a fusion mechanism
should be taken into consideration when developing lipoplexes
designed for in vivo or ex vivo nucleic acid transfer.
Interestingly, ON delivered with Nx lipoplexes are more active
that ON delivered with formulations close to neutrality while
precluding aggregation (conventionally observed when preparing
neutral membranes particles). This suggests that high positive
global net charge for lipoplexes is not a requirement for cell
transfection in contrast to the conclusions drawn from the
literature [7,13–15]. Thus, this observation might contribute to
pave the way for the development of less toxic and more efficient
lipoplexes.
Here we demonstrated that it is possible to obtain very good
splicing correction with negatively charged lipoplexes in serum-
containing medium at ON concentrations as low as 10 nM [30]
and data not shown] which is one of the lowest effective
concentrations described in the literature [47–50]. Pharmacolog-
ical considerations and delivery route are important when
considering splice switching ON for therapeutic use [48–50].
Although lipoplex formulations might increase treatment cost and
technological requirements, they might compensate these draw-
backs by making possible the use of potentially less toxic, non
modified splice switching ON with higher activity and specific
biodistribution. Controlling ON/lipoplex uptake cell mechanism
by design might influence cell targeting following systemic or local
administration and ex vivo ON strategies.
Supporting Information
Data S1
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